Start of final bull run ahead of 9th
November FDA announcement of Heplisav approval
$25-$30 price projection
I focus on stocks that are volatile and unpredictable. Based on the premise that the universe is describable by information, I quantify and digitize irrational trading behavior when asset prices are not supported by fundamentals.